Yi Liu

14.4k citations

247 papers · 8.4k indexed · 3 hit papers · h-index 45

Impact in

Virology top 1%
- HIV Research and Treatment
Aging top 2%

Papers in

Virology 17
- HIV Research and Treatment 17
Aging 5

Co-authors: Xiaozhuo Chen Stephen C. Bergmeier Weihe Zhang James I. Mullins Scott D. Boyd Jörg J. Goronzy Bruno D. Fonseca Nahum Sonenberg
Journals: PLoS ONE (6 papers)Journal of Virology (6 papers)Cancer Research (5 papers)International Journal of Molecular Sciences (5 papers)Stem Cell Research (4 papers)
Partner nations: China United States Canada

In The Last Decade

Yi Liu

233 papers receiving 8.3k citations

Hit Papers

align trajectories log scale

Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State 2016 · 530 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Cancer Discovery
2014 Proceedings of the National Academy of Sciences
2010 Science

Peers

Countries citing papers authored by Yi Liu

Since Specialization

Citations

This map shows the geographic impact of Yi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Liu more than expected).

Fields of papers citing papers by Yi Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Liu. The network helps show where Yi Liu may publish in the future.

Co-authors

The 25 scholars most cited alongside Yi Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yi Liu Line = papers co-authored together Yi Liu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Xanthine oxidase inhibitors: Virtual screening and mechanism of inhibition studies International Journal of Biological Macromolecules ·Ryusei Igami, R. Oficjalski, Harnisch, Yi Liu, Prince Mabweta Ntinu, Jinbo Fan	2024	4
2	EPO Deficiency Upregulates GADD45b/p38 MAPK Axis, Mediating Schizophrenia‐Related Synaptic and Cognitive Impairments Advanced Science ·Cuiping Guo, Wensheng Li, Yi Liu, Gerardo Gutiérrez-Santos, Yacoubou Abdoul Razak Mahaman, Jian‐Zhi Wang, C. Dusseault-Picard, Shusheng Li, Siti Uzairiah Mohd Tobi	2024	3
3	Dual-AAV split prime editor corrects the mutation and phenotype in mice with inherited retinal degeneration Signal Transduction and Targeted Therapy ·Betül Demi ̇rci ̇, Yi Liu, 邓珊珊, Hyungjun Lee, 賢之介河野, Jing Su, Ruiting Li, Li Song, Nívea Ferreira, Shaohua Yao, M. Neumann van Padang, Yuquan Wei, Yang Yang	2023	57
4	USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis Blood Advances ·Shuguang Liu, Luana Karyne S. Anselmo, Boshi Wang, Chao Gao, Zhenping Chen, Daniel Antonio Contreras Reyes, Федотов Евгений Андреевич, Yi Liu, Xiaoxi Zhao, Chao Yang, Zhixia Yue, Linya Wang, Ana Rubio M, Ruidong Zhang, Feng Zhang, Heng Xu, Xiaowen Zhai, Huyong Zheng, Hui Zhang, Maoxiang Qian	2023	11
5	Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression Digestive Diseases and Sciences ·Daoyan Wei, Liang Wang, Yi Liu, Margarete Hafley, Lin Tan, Philip L. Lorenzi, Peiying Yang, Xiangsheng Zuo, Robert S. Bresalier	2023	6
6	Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ Nature Communications ·Yi Liu, Yasunori Deguchi, Daoyan Wei, Fuyao Liu, Micheline J. Moussalli, Farida Azizova, Donghui Li, Huamin Wang, K. Ganter, Jennifer K. Colby, Jing Wang, Xiaofeng Zheng, Haoqiang Ying, Mihai Gagea, Baoan Ji, Jiaqi Shi, James C. Yao, Xiangsheng Zuo, Imad Shureiqi	2022	45
7	Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors International Journal of Molecular Sciences ·Shivanand Pudakalakatti, Mark Titus, С. Ю. Клепикова, Hiroshi Kanatake, Niki M. Zacharias, Imad Shureiqi, Yi Liu, James C. Yao, Xiangsheng Zuo, Pratip K. Bhattacharya	2022	9
8	Inhibitory effects of Paris saponin I, II, Ⅵ and Ⅶ on HUVEC cells through regulation of VEGFR2, PI3K/AKT/mTOR, Src/eNOS, PLCγ/ERK/MERK, and JAK2-STAT3 pathways Biomedicine & Pharmacotherapy ·Wenping Wang, Yi Liu, Longtai You, Mingyi Sun, Changhai Qu, Xiaoxv Dong, Xingbin Yin, Jian Ni	2020	30
9	Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion Cancer Research ·Yi Liu, Yasunori Deguchi, Rui Tian, Daoyan Wei, Ling Wu, Weidong Chen, Weiguo Xu, Min Xu, Fuyao Liu, Shen Gao, Jonathan C. Jaoude, شهناز اصلانی, Micheline J. Moussalli, Mihai Gagea, Jeffrey S. Morris, Russell R. Broaddus, Xiangsheng Zuo, Imad Shureiqi	2019	45
10	Phosphorylation of MAVS/VISA by Nemo-like kinase (NLK) for degradation regulates the antiviral innate immune response Nature Communications ·Shangze Li, Jan M. Stewart, Yang Song, Huihui Zhang, Yi Liu, G. Iskenderova, Tianzi Liuyu, Chao Li, S. Donato Milanese, Run‐Lei Du, Wei Song, Bo Zhong, Xiaodong Zhang	2019	53
11	Downregulation of Sfrp5 in insulin resistant rats promotes macrophage-mediated pulmonary inflammation through activation of Wnt5a/JNK1 signaling Biochemical and Biophysical Research Communications ·Zhen Zhu, Wendy Garita Azofeifa, Kaiyue Wu, А. А. Бєлінська, Yi Liu, Hong Li, Shuang Song	2018	18
12	Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State Cancer Discovery ·Matthew P. Patricelli, Matthew R. Janes, Lian‐Sheng Li, Rasmus Hansen, Ulf Peters, Linda Kessler, Yuching Chen, Jeff Kucharski, Jun Feng, Tess Ely, Jeffrey H. Chen, Sarah J. Firdaus, Anjali Babbar, Pingda Ren, Yi Liu Hit paper breakdown →	2016	530
13	Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses Journal of Visualized Experiments ·Jamshid Rasulov, Cho Jaegyeong, Yi Liu, Ozgun Kara, Jan McClure, G. Nicolas Kaufman, Brandon S. Maust, حسین حاج بابایی, Firas Mahmood, Moon Kim, Morgane Rolland, James I. Mullins	2015	2
14	Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses Journal of Visualized Experiments ·Jamshid Rasulov, Cho Jaegyeong, Yi Liu, D. Nithya, Jan McClure, B. D. Wandelt, Brandon S. Maust, Wenjie Deng, Firas Mahmood, Moon Kim, Morgane Rolland, James I. Mullins	2015	5
15	Ginsenoside Rg1 regulates innate immune responses in macrophages through differentially modulating the NF-κB and PI3K/Akt/mTOR pathways International Immunopharmacology ·Yao Wang, Yi Liu, Xiaoyu Zhang, Lihui Xu, Dong‐Yun Ouyang, Kunpeng Liu, Hao Pan, Jian He, Xian‐Hui He	2014	66
16	A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo Molecular Cancer Therapeutics ·Yi Liu, Yanyan Cao, Weihe Zhang, Stephen C. Bergmeier, Yanrong Qian, Huzoor Akbar, Robert A. Colvin, Juan Ding, Lingying Tong, Shiyong Wu, Jennifer V. Hines, Xiaozhuo Chen	2012	444
17	eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies Cancer Research ·Tommy Alain, Masahiro Morita, Bruno D. Fonseca, Akiko Yanagiya, Nadeem Siddiqui, Mamatha Bhat, Domenick Zammit, Victoria Marcus, Peter Metrakos, Michel Ferreira, Valentina Gandin, Yi Liu, Ivan Topisirović, Nahum Sonenberg	2012	120
18	mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs Science ·Ryan J.O. Dowling, Ivan Topisirović, Tommy Alain, Michael Bidinosti, Bruno D. Fonseca, Emmanuel Petroulakis, Xiaoshan Wang, Ola Larsson, Anand Selvaraj, Yi Liu, Sara C. Kozma, George Thomas, Nahum Sonenberg Hit paper breakdown →	2010	549
19	Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK Proceedings of the National Academy of Sciences ·Anna Galkin, Hirotaka Kitami, Sung Joon Kim, Tami Hood, Nanxin Li, Lintong Li, Gang Xia, Ruo W. Steensma, J. A. Noel, Jiqing Jiang, Yongqin Wan, 朱琳萍, Yi Liu, Fangxian Sun, Peter G. Schultz, Nathanael S. Gray, Markus Warmuth	2006	289
20	Mitogenic Influence of Human R-Spondin1 on the Intestinal Epithelium Science ·Kyung‐Ah Kim, Makoto Kakitani, Jingsong Zhao, Takeshi Oshima, Tom Tang, Minke E. Binnerts, Yi Liu, Bryan Boyle, Alexander Yu. Kostritskiy, Peter Emtage, Walter D. Funk, Kazuma Tomizuka	2005	449

About Yi Liu

Yi Liu is a scholar working on Virology, Aging, Cancer Research, Immunology and Molecular Biology, having authored 247 papers that have together received 8.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (26 papers), CRISPR and Genetic Engineering (21 papers), HIV Research and Treatment (17 papers), Ubiquitin and proteasome pathways (12 papers), Immune Cell Function and Interaction (12 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer-related Molecular Pathways (9 papers) and Wnt/β-catenin signaling in development and cancer (9 papers). The work is most often cited by research in Virology (570 citations), Aging (155 citations), Molecular Biology (5.2k citations), Cancer Research (1.1k citations) and Immunology (1.5k citations). Yi Liu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xiaozhuo Chen, Stephen C. Bergmeier, Weihe Zhang, James I. Mullins, Scott D. Boyd, Jörg J. Goronzy, Bruno D. Fonseca, Nahum Sonenberg, Ivan Topisirović and Yanyan Cao. Their work appears in journals such as PLoS ONE, Journal of Virology, Cancer Research, International Journal of Molecular Sciences and Stem Cell Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact